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ABSTRACT Human acidic fibroblast growth factor (FGF-1) is a powerful mitogen and angiogenic factor with an apparent
melting temperature (Tm) in the physiological range. FGF-1 is an example of a protein that is regulated, in part, by
stability-based mechanisms. For example, the low Tm of FGF-1 has been postulated to play an important role in the unusual
endoplasmic reticulum-independent secretion of this growth factor. Despite the close relationship between function and
stability, accurate thermodynamic parameters of unfolding for FGF-1 have been unavailable, presumably due to effects of
irreversible thermal denaturation. Here we report the determination of thermodynamic parameters of unfolding (H, G, and
Cp) for FGF-1 using differential scanning calorimetry (DSC). The thermal denaturation is demonstrated to be two-state and
reversible upon the addition of low concentrations of added guanidine hydrochloride (GuHCl). G values from the DSC
studies are in excellent agreement with values from isothermal GuHCl denaturation monitored by fluorescence and circular
dichroism (CD) spectroscopy. Furthermore, the results indicate that irreversible denaturation is closely associated with the
formation of an unfolding intermediate. GuHCl appears to promote reversible two-state denaturation by initially preventing
aggregation of this unfolding intermediate, and at subsequently higher concentrations, by preventing formation of the
intermediate.
INTRODUCTION
Human acidic fibroblast growth factor (FGF-1) is a member
of a family of mitogens and hormones whose diverse action
is mediated through tyrosine kinase receptors (Bourque et
al., 1993; Mellin et al., 1992; Fitzpatrick et al., 1992; Ortega
et al., 1998; Deng et al., 1996; Colvin et al., 1996; Slack et
al., 1987). Various members of the FGF family are potent
angiogenic factors (Thomas et al., 1985; Thompson et al.,
1989; Schneider and Parker, 1991; Yanagisawa-Miwa et al.,
1992), with potential use in “angiogenic therapy” to treat
ischemia (Landau et al., 1995; Unger et al., 1994; Yanagi-
sawa-Miwa et al., 1992; Pu et al., 1993; Thompson et al.,
1989; Nabel et al., 1993; Schlaudraff et al., 1993; Schuma-
cher et al., 1998). These growth factors are also termed
“heparin binding” growth factors due to their specific affin-
ity for this polysulfonated polysaccharide. Early character-
ization of FGF-1 indicated that binding of heparin could
protect the protein from denaturation by acid, proteolysis,
and mild oxidation (Gospodarowicz and Cheng, 1986;
Rosengart et al., 1988; Linemeyer et al., 1990). Differential
scanning calorimetry (DSC) by Middaugh and coworkers
(Copeland et al., 1991) suggested that the melting temper-
ature (Tm) of FGF-1 is close to physiological. However,
other thermodynamic parameters (i.e., H, G, or Cp)
were not reported, presumably due to irreversible denatur-
ation. The interaction of FGF-1 with heparin was reported
by this group to increase the Tm by 20 K. This provided a
rationale for the protection of FGF-1 by heparin against
thermal denaturation and proteolysis. The low Tm of FGF-1
seems a paradox: why would a protein have a thermal
stability that results in a significant population of molecules
being unfolded (and therefore inactive) in the temperature
regime within which they are intended to function?
The thermal stability of FGF-1 may provide an important
regulatory mechanism with regard to membrane transloca-
tion and cell secretion. FGF-1, like basic FGF (FGF-2),
lacks a characteristic secretion signal sequence (Abraham et
al., 1986; Jaye et al., 1986) and is secreted by an endoplas-
mic reticulum-independent mechanism. Cytosolic FGF-1 is
secreted in response to heat shock, and appears to have a
different conformation from the native protein (Jackson et
al., 1992). A fusion protein of FGF-1 and diphtheria toxin
has been reported to translocate across the cytosolic mem-
brane, but only under low pH conditions and not if FGF-1
is stabilized by binding sulfate ion or sulfonated molecules
(Wiedlocha et al., 1992). FGF-1 has subsequently been
shown to form partially structured states under such acidic
conditions (Mach et al., 1993; Sanz and Gimenez-Gallego,
1997). Furthermore, these partially structured states can
interact with negatively charged phospholipid vesicles, con-
tributing to disruption of such vesicles (Mach and Mid-
daugh, 1995). Thus, the low thermal stability of FGF-1 may
be related to the ability to form partially structured states at
physiological temperatures that can directly translocate
across cellular membranes (Bychkova et al., 1988). In the
case of secretion, once outside the cell, binding to heparin in
the extracellular matrix or heparan sulfate on the surface of
cells, can stabilize FGF-1. Therefore, modulation of the
stability of FGF-1 is an essential aspect of its regulation and
function.
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Despite the importance of stability to the function of
FGF-1, detailed thermodynamic parameters of unfolding
have not been available. Here we report the use of low
concentrations of guanidine hydrochloride (GuHCl) to pre-
vent aggregation during thermal denaturation of FGF-1,
thus allowing the determination of thermodynamic param-
eters of unfolding (H, Tm, and Cp). The data are com-
pared to GuHCl-induced unfolding under isothermal condi-
tions using a combination of fluorescence and circular
dichroism (CD) spectroscopy. The results from the different
methods are in excellent agreement. The analysis elucidates
the role of an unfolding intermediate in the thermal aggre-
gation of FGF-1 and the role of GuHCl in promoting two-
state thermal denaturation.
MATERIALS AND METHODS
The choice of buffer with which to perform DSC, CD, and fluorescent
studies was of primary concern. DSC analysis requires a buffer with a low
ionization enthalpy, while the spectroscopic studies require buffers that
will not absorb significantly over the wavelength of interest. Furthermore,
thermodynamic data are of greatest value when collected under conditions
similar to those used for other structural and functional studies. Since the
crystal structure of FGF was solved at pH 6.2 (Blaber et al., 1996) and
biological assays are performed near pH 7.4, a buffer with a pKa in this
region was desirable. Although phosphate buffer is an excellent choice for
DSC studies due to its low ionization enthalpy, crystallographic studies
have demonstrated that FGF-1 will bind phosphate ions (Romero et al.,
1996). Furthermore, this binding site in FGF-1 can also bind sulfate ions
(Blaber et al., 1996), thus sulfonic acid-based buffers can also potentially
bind to FGF-1. Binding of such ions by FGF-1 can increase the protein
stability (Blaber et al., 1997). Although N-(2-acetamido)iminodiacetic acid
(ADA; pKa  6.60) can interfere with CD measurements below 210 nm,
it is a good compromise for overall use in the DSC, CD, and fluorescence
studies.
Protein preparation
A synthetic gene for the 140 amino acid form of human acidic fibroblast
growth factor (Gimenez-Gallego et al., 1986; Linemeyer et al., 1987) was
inserted into the PET-21 vector (Novagen, Inc., Madison, WI) and intro-
duced into Escherichia coli strain BL21(DE3). The transformed E. coli was
grown at 37°C in M9 minimal media (Sambrook et al., 1989) to an optical
density of A600  1.5, at which point the temperature was shifted to 28°C
and expression of FGF was induced by the addition of 1 mM isopropyl
-D-thiogalactopyranoside (IPTG). The cells were allowed to grow for an
additional 3.0 h and were then harvested by centrifugation (5,000  g for
10 min). The cell paste was stored frozen at20°C before use. Purification
to apparent homogeneity on Coomassie Brilliant Blue-stained sodium
dodecyl sulfate (SDS) gels was accomplished using a combination of
Carboxymethyl- and Sulphopropyl-Sephadex ion exchange resins, fol-
lowed by Sephadex G-50 gel filtration chromatography and heparin-Sepha-
rose affinity chromatography (all resins from Pharmacia, Piscataway, NJ).
Details of the purification procedure will be provided elsewhere. The
purified protein was concentrated to 1.2 mg/ml using a pressure cell and
YM-10 membrane (Amicon, Beverly, MA) and dialyzed versus three 1:100
vol/vol changes of 20 mM N-(2-acetamido)iminodiacetic acid (ADA), 0.1
M NaCl pH 6.60 (“ADA buffer”) using Spectrapore 1 (6–8 kDa cutoff)
dialysis tubing (Spectrum Industries, Houston, TX). The dialyzed protein
was filtered using a 0.2 m syringe filter (Gellman Sciences, Ann Arbor,
MI) and diluted to 1.0 mg/ml with ADA buffer. The protein sample was
then aliquoted and stored frozen at 80°C before use. Protein concentra-
tions were determined using an extinction coefficient E (0.1%, 1 cm) 
1.26 at 280 nm and a molecular mass of 15.9 kDa (Zazo et al., 1992; Tsai
et al., 1993). For studies involving the addition of GuHCl a stock solution
of 8 M GuHCl in ADA buffer was made by addition of GuHCl (Heico
Chemical, Delaware Water Gap, PA) to ADA buffer, followed by 0.2 m
filtration. The final concentration of GuHCl in this stock solution was
determined by refractive index measurement (Shirley, 1995). Thawed
protein samples were filtered using a 0.2 m syringe filter (Gelman
Sciences), and diluted in filtered ADA buffer or GuHCl/ADA buffer to a
final concentration of 0.038 mM for all studies.
DSC
DSC analyses were performed using a model VP-DSC microcalorimeter
(MicroCal, Inc., Northampton, MA). All samples were degassed for 15 min
prior to loading, and analyses were performed under 35 psi nitrogen gas.
Unless otherwise indicated, all studies were performed by scanning from
low to high temperature (“upscans”) at 15 K/h. In all cases, a series of
repetitive buffer/buffer scans were run and after establishing a repeatable
buffer/buffer baseline, protein samples were introduced at 298 K during the
cooling phase preceding the next scan cycle. In this way repetitive protein
scans were collected with minimal thermal disruption and without inter-
rupting the scan cycle. Data from the second protein run were typically the
most reproducible, and these data were used for analysis. Each experiment
was repeated and data from duplicate experiments were averaged.
Analysis of the DSC data was performed using both a statistical me-
chanics-based deconvolution (Freire and Biltonen, 1978; Kidokoro and
Wada, 1987) as implemented in the DDCL1 software package (Kidokoro
and Wada, 1987; Kidokoro et al., 1988; Nakagawa and Oyanagi, 1980),
and a nonlinear least-squares fit to a two-state model (Kidokoro and Wada,
1987; Kidokoro et al., 1988) using the general-purpose nonlinear fitting
program DataFit (Oakdale Engineering, Oakdale, PA). The two-state
model utilized is as follows:
CpT CNT CpT  1 FNT
	 HT2  FNT  1 FNTRT 2 
where CN(T) is the linear heat capacity function of the native state, Cp(T)
is the temperature-dependent difference heat capacity function between the
native and denatured states, FN(T) is the temperature-dependent native
state fractional component, and H(T) is the temperature-dependent en-
thalpy of the system. The thermodynamic parameters of unfolding were
determined from the nonlinear fit to the two-state model. Deviation from
two-state behavior was determined by comparing van’t Hoff and calori-
metric enthalpies from the deconvolution analysis, the fractional compo-
nent of intermediate states as determined by the deconvolution analysis,
and by the error associated with the nonlinear fit to a two-state function.
For the DSC data, G as a function of temperature was calculated as
follows:
GTDA  T  T Tm
 DB  T  ln  TTm DC  1 TTm
where DA, DB, and DC are terms of the second-order polynomial function
describing H of unfolding and Tm is the melting temperature (Kidokoro
and Wada, 1987; Kidokoro et al., 1988).
Fluorescence
Samples of FGF-1 in GuHCl/ADA buffer were allowed to equilibrate by
overnight incubation at 4°C. Spectroscopic measurements were performed
using a model FL1T1-Tau Fluorolog-Tau2 spectrofluorometer (ISA SPEX,
Edison, NJ). Temperature control was achieved using a model RTE-3
circulating water bath (NESLAB, Portsmouth, NH). All experiments were
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carried out at 298 K using a 10-mm pathlength cuvette. An excitation
wavelength of 295 nm was used to preferentially excite the single trypto-
phan residue and to minimize excitation of the eight tyrosine residues
present in FGF-1 (Gimenez-Gallego et al., 1986). Excitation and emission
slits were set to 0.5 nm. Emission spectra were collected from 300 to 500
nm in 1.0-nm increments with a 0.5-s integration time. Scans were col-
lected in triplicate for each sample, duplicate samples were analyzed, and
the results averaged. For each protein sample, buffer baselines with the
same concentration of GuHCl concentration were subtracted from the
averaged protein scan. The total fluorescence from 300 to 500 nm was
determined by integration of these buffer-subtracted protein scans. The
fluorescence data were analyzed using the general-purpose nonlinear fit-
ting program DataFit (Oakdale Engineering) using a six-parameter, two-
state model (Eftink, 1994):
F
F0N SN  
D FoD SD  
D
 exp G0 m  
D/RT
1 exp G0 m  
D/RT
where the denaturant concentration is given by [D], the native state (0 M
denaturant) fluorescence intercept and slope are F0N and SN, respectively,
the denatured state fluorescence intercept and slope are F0D and SD,
respectively, and the free energy of unfolding function intercept and slope
are G0 and m, respectively.
Circular dichroism
Samples of FGF-1 in GuHCl/ADA buffer were allowed to equilibrate by
overnight incubation at 4°C. Circular dichroism measurements were car-
ried out with a model 62A DS circular dichroism spectrometer (AVIV,
Burlington, MA), fitted with a thermoelectric cuvette holder, and interfaced
with a model CFT-33 refrigerated recirculator (NESLAB). Isothermal (298
K) CD spectra were acquired by scanning from 260 nm down to 210 nm
in 1-nm increments with a 1-nm bandwidth. A 1-mm pathlength cuvette
was used to minimize the absorption effect from ADA buffer in the far UV
range. Triplicate scans were recorded for each protein sample, duplicate
samples were analyzed and averaged. After subtraction of buffer from
protein spectra, the data were converted to molar ellipticity (deg  cm2 
dmol1). A difference CD spectrum for FGF-1, comparing native and
denatured states, exhibits a maximum at 227 nm. Therefore, thermal scans
at fixed denaturant concentrations were performed by following the molar
ellipticity at 227 nm as a function of temperature. Thermal denaturation
data were collected using a scan rate of 15 K/h (identical to the DSC
analysis). The CD data were analyzed using a six-parameter, two-state
model as described above.
RESULTS
DSC
Initial analyses indicated that DSC data collected at the
commonly used scan rate of 60 K/h were unreliable due to
a hysteresis of 4 K between upscan and downscan data.
No such hysteresis is observed when the scan rate is reduced
to 15 K/h (Fig. 1), the scan rate chosen for all studies. The
first and second upscan of FGF-1 in various concentrations
of GuHCl are shown in Fig. 2. In ADA buffer alone, the
DSC trace is characterized by 1) an apparent negative value
for Cp, 2) noise in the post-transition baseline, 3) no
endothermic signal on the second scan, and 4) visible pre-
cipitation after thermal denaturation (Fig. 2). These features
reflect the combined effects of the denaturation endotherm,
precipitation exotherm, and noise due to nonhomogenous
distribution of the precipitated sample within the cell. Cp
values for soluble proteins are positive and typically in the
range of 0.30–0.70 J g1 K1 (Privalov, 1979; Privalov and
Potekhin, 1986) and the aberrant negative value for Cp
reflects the (exothermic) precipitation process.
In an attempt to eliminate precipitation and obtain revers-
ible thermal denaturation, the effect of added denaturant
was investigated. With the addition of 0.4 M GuHCl in the
ADA buffer, there was a recovery of 16% of the dena-
turation enthalpy during a subsequent upscan (Fig. 2). Qual-
itatively, the precipitation in this sample appeared as a
diffuse opacity and not an aggregation at the bottom of the
sample (as observed in the ADA buffer in the absence of
denaturant); however, the value for Cp remained negative.
At 0.5 M GuHCl, a small amount of precipitation was
visible after thermal denaturation, and the recovery of cal-
orimetric enthalpy on a subsequent scan increased to40%
(Fig. 2). Cp remained negative, however, indicating the
presence of aggregation. Upon the addition of 0.6 M GuHCl
there was 1) no precipitation, 2) no noise in the post-
transition baseline, 3) a highly repeatable endotherm in
subsequent scans, and 4) a positive value for Cp (Fig. 2,
Table 1).
Although the thermal denaturation in 0.6 M GuHCl is
reversible with no precipitation, double deconvolution anal-
ysis (Kidokoro and Wada, 1987; Kidokoro et al., 1988;
Nakagawa and Oyanagi, 1980) of the DSC data indicates
the denaturation is non-two-state, and that an unfolding
intermediate is present (Fig. 3). An unfolding intermediate
is also indicated by the characteristic deviation of the ob-
served isotherm from a nonlinear least-squares fit to a
two-state model (Kidokoro and Wada, 1987; Kidokoro et
al., 1988) (Fig. 4, Table 1). Additionally, the ratio of the
van’t Hoff to calorimetric enthalpies yields a value of 0.50
FIGURE 1 DSC endotherms (upscans in solid lines, downscans in bro-
ken lines) of FGF-1 at either 60 K/h (thin lines) or 15 K/h (thick lines). A
hysteresis of 4 K is observed at the 60 K/h scan rate, while no hysteresis
is observed at the 15 K/h scan rate. All samples contain 0.7 M GuHCl in
ADA buffer.
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(Table 1), characteristic of an unfolding intermediate. With
an increase in the concentration of GuHCl to 0.7 M, there is
no evidence of an unfolding intermediate in the double
deconvolution analysis (Fig. 3). Furthermore, there is ex-
cellent agreement of the observed isotherm with the non-
linear least-squares fit to a two-state model (Fig. 4, Table 1)
and the ratio of the van’t Hoff to calorimetric enthalpy is
essentially 1.0 (Table 1). The root mean square (RMS)
deviation between the experimental data and a two-state fit
for all data between 0.7 and 1.0 M GuHCl is equivalent to
the noise level of the instrument (Table 1). The data at 1.1
M GuHCl have somewhat higher error, reflecting the small
enthalpic signal under these conditions. At a concentration
1.1 M GuHCl, the enthalpy decreases to the point where
it is difficult to collect accurate data. Furthermore, at con-
centrations of GuHCl 1.1 M FGF-1 appears to be signif-
icantly unfolded even at the initial temperature of the DSC
analysis. Thus, the deviation from unity of the van’t Hoff/
calorimetric enthalpy for the 1.1 M GuHCl sample may
reflect the partially unfolded state of the sample at low
temperature. Over the range of added GuHCl where two-
state behavior is demonstrated (0.7–1.1 M GuHCl), Cp
remains relatively constant with an average value of
0.587  0.036 J g1 K1 (Table 1). This value is less than
a previously reported value of 0.74 J g1 K1 estimated
from urea denaturation experiments performed in phosphate
buffer (Burke et al., 1993).
Isothermal equilibrium denaturation: fluorescence
Isothermal equilibrium denaturation of FGF-1 by GuHCl in
ADA buffer was monitored by the intrinsic fluorescence
emission spectra of the single tryptophan residue in FGF-1
(Gimenez-Gallego et al., 1986; Linemeyer et al., 1987).
With increasing GuHCl, there is an increase in the fluores-
cence emission intensity without a change in the max (353
nm) for emission (Fig. 5). Calculation of thermodynamic
constants yields an m value of 19.44 kJ L mol2, and a
value for G at 0M denaturant of 21.92 kJ mol1 (Table 2).
The midpoint of the denaturation occurs at a concentration
of 1.13 M GuHCl.
Isothermal equilibrium denaturation:
circular dichroism
Isothermal equilibrium denaturation monitored by changes
in CD spectrum provides a more global analysis than the
fluorescence spectra. The CD spectrum of FGF-1 can be
measured to 210 nm in the far UV range due to the
absorbance of the ADA buffer at shorter wavelengths. Over
the far UV region, the molar ellipticity of native FGF-1
exhibits a maximum at 227 nm. In response to increasing
GuHCl, the molar ellipticity decreases (Fig. 5). The wave-
length peak of the native spectrum (227 nm) is also the peak
of the differential spectrum between native and denatured
states. Calculation of thermodynamic constants yields an m
value of 18.67 kJ L mol2, and a value for G at 0 M
denaturant of 20.76 kJ mol1 (Table 2). The midpoint of the
denaturation occurs at a concentration of 1.11 M GuHCl. A
similar analysis using the absorbance signal at 222 nm gives
essentially identical results (data not shown). Protein ab-
sorbing to the quartz cuvettes prevented thermal denatur-
ation studies of FGF-1 using CD spectroscopy. No such
absorbance was observed in the isothermal denaturant stud-
ies, using either CD or fluorescence, or thermal DSC scans
(with a Tantalum cell).
DISCUSSION
DSC
Thermal denaturation of FGF-1 in the absence of GuHCl
results in significant precipitation and thus is not an equi-
librium process. Such endotherms cannot be deconvoluted
using models that assume equilibrium. Decreasing precipi-
tation and increasing recovery of enthalpy is demonstrated
FIGURE 2 DSC endotherms for the initial (top) and subsequent (bottom)
upscan of FGF-1 in concentrations of GuHCl from 0.0 to 1.1 M in ADA
buffer at pH 6.60.
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with the addition of 0.4 and 0.5 M GuHCl. At concentra-
tions of 0.6 M GuHCl and higher, there is an absence of
precipitation and a recovery of essentially all the enthalpy
on subsequent scans. Thus, at concentrations of 0.6 M
GuHCl and higher, the two-state model can be evaluated
using the equilibrium assumption. The DSC endotherm of
the 0.6 M GuHCl sample is consistent with the presence of
an unfolding intermediate, while at higher concentrations of
denaturant there is excellent agreement with the two-state
model. Although deconvolution analysis of the 0.4 and 0.5
M GuHCl data also indicates the presence of an unfolding
intermediate (data not shown), the precipitation present
under these conditions precludes accurate analyses of ther-
modynamic parameters. GuHCl may promote reversible
denaturation of FGF-1 by preventing aggregation of the
unfolding intermediate. At higher concentrations (0.7 M and
TABLE 1 Thermodynamic parameters of unfolding for denaturation of FGF-1 in the presence of GuHCl and under
equilibrium conditions
GuHC
(M)
H(Tm)
(kJ mol1)
Tm
(°K)
Cp(Tm)
(J g1 K1)
2-State Fit RMS
(kJ mol1 K1)* Hvan’t Hoff/Hcal
Repeatability
(%)
0.6 305.6  3.4 315.7  0.1 0.160  0.012 1.41 0.50 85
0.7 257.3  3.1 312.6  0.1 0.409  0.033 0.18 1.08 93
0.8 234.4  3.7 310.1  0.2 0.525  0.043 0.12 1.04 90
0.9 197.0  2.9 307.0  0.2 0.621  0.025 0.13 1.05 95
1.0 171.9  2.5 304.8  0.2 0.577  0.025 0.14 1.03 83
1.1 123.1  11.6 299.9  0.8 0.639  0.043 0.21 1.25 88
Reported error refers to the deviation from the fit to a two-state model.
*RMS deviation for the fitted function in comparison with the raw data.
FIGURE 3 Temperature dependence of the fractional composition of
native (FN) and denatured (FD) states of FGF-1 as determined by the
double-deconvolution of the DSC data. The presence of an intermediate
state is calculated by 1  (FN 	 FD). Data are shown for ADA buffer with
the addition of 0.6 M GuHCl (top), and 0.7 M GuHCl (bottom).
FIGURE 4 FGF-1 DSC denaturation endotherms (solid lines) and non-
linear least squares fit to a two-state model (Kidokoro and Wada, 1987;
Kidokoro et al., 1988) (broken lines). The top panel shows the endotherm
in the presence of 0.6 M GuHCl and the bottom panel shows the endotherm
in 0.7 M GuHCl.
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higher) GuHCl promotes two-state denaturation by prevent-
ing formation of (i.e., destabilizing) the unfolding interme-
diate. Continued addition of GuHCl leads to denaturation of
the native state of FGF-1.
Isothermal equilibrium denaturation
The deconvolution of the CD and fluorescence data to yield
fractional denatured state as a function of denaturant con-
centration demonstrates excellent agreement between the
two methods (Fig. 6). Therefore, local unfolding near tryp-
tophan 107 occurs simultaneously with the unfolding of
secondary and tertiary features of the protein. Thus, a two-
state model during isothermal equilibrium GuHCl induced
unfolding of FGF-1 is supported. There is no evidence for
an unfolding intermediate when FGF-1 is denatured using
GuHCl under isothermal conditions at 298 K. The midpoint
of the unfolding transition occurs at1.13 M GuHCl at this
temperature. This relatively high concentration of GuHCl
may therefore prevent formation of an unfolding interme-
diate. Thus, there is a critical range of temperature and
denaturant which allows isolation of a soluble unfolding
intermediate.
Comparison of isothermal equilibrium and
DSC data
For each concentration of denaturant in the DSC studies,
G can be calculated at the isothermal reference tempera-
ture (298 K) used in the CD and fluorescence studies. Thus,
G as a function of denaturant can be directly compared for
the three methods. The extrapolated values for G at 0 M
denaturant (i.e., G0), m values, and concentrations of de-
naturant at G  0 are listed in Table 2. Over the range of
denaturant where the DSC data exhibit two-state reversible
denaturation (0.7–1.1 M) there is excellent agreement
among the DSC, CD, and fluorescence studies (Fig. 7). The
average value of G0 (21.30  0.58 kJ mol
1) is less than
the value (27.22 kJ mol1) reported from urea-induced
denaturation of FGF-1 at pH 7.0 (Burke et al., 1993).
However, this study was performed in phosphate buffer,
which can bind and stabilize FGF-1 (Romero et al., 1996;
Blaber et al., 1997). The temperature at which G is a
TABLE 2 Comparison of G for DSC, CD, and
fluorescence studies
Method
G0
(kJ mol1)
m Value
(kJ L mol2)
GuHC (M)
@ G  0
Fluorescence 21.92  0.26 19.44  0.22 1.13  0.01
CD 20.76  0.39 18.67  0.35 1.11  0.02
DSC 21.22  1.00 18.26  1.04 1.16  0.05
Average 21.30  0.58 18.79  0.60 1.13  0.03
The DSC data are determined at the reference temperature of 298.15 K and
includes data over the range of GuHCl where the reversible denaturation is
two-state (i.e., 0.7–1.1 M). The values of G for all studies are the
extrapolated values at 0 M denaturant. Reported error is from the linear fit
to the data.
FIGURE 5 Fluorescence emission spectra of FGF-1 as a function of
GuHCl (top). The fluorescence of FGF-1 increases with increasing GuHCl,
with a characteristic maximum at 353 nm. CD spectra of FGF-1 as a
function of GuHCl in the far UV range (bottom). The CD spectra of FGF-1
decrease over the far UV range as a function of GuHCl, with a character-
istic maximum at 227 nm.
FIGURE 6 A comparison of the deconvolution of CD (open squares)
and fluorescence data (open triangles) to yield a fractional denatured state
as a function of GuHCl.
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maximum can be calculated from the derivative of the G
function for the DSC data, yielding a value of 289.75  2.7
K (16.6°C). Linear extrapolation of Tm values to 0 M
denaturant yields a surprising value of 59°C. This is signif-
icantly higher than the apparent Tm derived for FGF-1
under irreversible conditions (Copeland et al., 1991). Pre-
cipitation, being an irreversible process, will perturb the
unfolding equilibrium, resulting in a lower apparent Tm
value. Additionally, it cannot be ruled out that the native
structure of FGF-1 is stabilized at low concentrations of
GuHCl. However, no evidence for such initial stabilization
is present in either the CD or fluorescent spectroscopic data
for the isothermal GuHCl-induced denaturation (Fig. 6).
The addition of relatively low concentrations of GuHCl
promotes the equilibrium two-state conditions necessary for
accurate thermodynamic analysis of FGF-1. This, in turn,
will allow thermodynamic studies of mutations designed to
probe structure and stability relationships. Although the
present study is performed under near-physiological condi-
tions of pH, the presence of GuHCl will perturb the G of
unfolding in comparison to actual physiological conditions.
However, the critical parameter of interest in mutant studies
is typically the difference in the G of unfolding (G)
between mutant and wild-type protein, and not the absolute
value of G. Finally, the identification of conditions for the
solubilization of an unfolding intermediate of FGF-1 will
aid in characterization of its physical properties and structure.
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